Please select the option that best describes you:
Do you offer neoadjuvant chemotherapy to nested variant urothelial carcinoma (NVUC) of the bladder?
Assume a case where NVUC is the majority/pure variant, rather than just a focus of variant disease in UC background. Data seem to suggest response to NAC may be poor?